InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
Bullish
Bullish
profile icon
namtae Free
30 minutes ago
Bullish
Bullish
profile icon
NASDAQ2020 PremiumMember
06/23/25 8:20 PM
Bullish
Bullish
profile icon
HenryB3 Free
06/23/25 7:27 PM
profile icon
kennyt 335 Free
06/23/25 6:46 PM
profile icon
jimr1717 Free
06/23/25 6:33 PM
profile icon
BZ2 Free
06/23/25 6:31 PM

Elite Pharmaceuticals Inc (ELTP) RSS Feed

Followers
1140
Posters
Posts (Today)
26
Posts (Total)
429373
Created
03/24/09
Type
Free
Moderators Dr Speculator Ninja mrwrn2010 NASDAQ2020 namtae

 

Fiscal Year: 2024
Revenue: $56,625,128
Change: +65.79%
Net Income: $20,108,631
Change: +464.56%
 
 



 


Senior Moderator: NASDAQ2020
Posted: 7/02/2024

________________________________________________________________________________________________________________


Elite Pharmaceuticals, Inc.
 

Website

Location

Employees

Facility

CEO
www.elitepharma.com
 
Northvale, New Jersey
 
64
 
85,000 sq ft
 
Nasrat Hakim
 
 
 
Products & Pipeline
 

Drug

Market Size

Status

Competitors

Marketed By
Adderall IR 421.7 M On Market 16 Elite, Dexcel
Adderall XR 865 M On Market 10 Elite
Dantrolene 6.3 M On Market 2 Elite
Isradipine 5.5 M On Market 1 Elite
Loxapine 5 M On Market 2 Elite
Phendimetrazine 4.5 M On Market 4 Elite
Trimipramine 2 M On Market 1 Elite
Naltrexone 16 M On Market 5 Precision Dose
Phentermine Capsules 7.5 M On Market 6 Precision Dose
Phentermine Tablets 40 M On Market 8 Precision Dose
Vigabatrin 233.7 M On Market 13 Pyros
Doxycycline 85 M Approved (Discontinued) 9 ----------
Tylenol with Codeine 47 M  On Market 5 Elite
Dopamine Agonist 12 M Filed with FDA -  Dec 22, 2022 ---------- ----------
Methotrexate 63 M On Market 8 Elite
Percocet 317 M  On Market 14 Elite
Norco 300 M   On Market  12 Elite
Methadone 30 M Approved in Launch Queue 8 ----------
 OxyContin 720 M Filed with FDA - Aug 17, 2023 4 ----------
 Vyvanse  4.3 B On Market 13 Elite
 Concerta 1.16 B BE Studies 8 ----------
Undisclosed ANDA 27 B Positive BE Study 1 -----------
 
 
Financials
 

Fiscal Year

Revenue

Change

Net Income

Change
2019 7,568,508 ---------- (9,279,321) ----------
2020 17,994,639 +137.76% (2,240,351) +75.86%
2021 25,380,749 +41.05% 5,088,421 +327.13%
2022 32,262,117 +27.11% 8,898,245 +74.87%
2023 34,155,114 +5.87% 3,561,846 -59.97%
2024 56,625,128 +65.79% 20,108,631 +464.56%
2025 Q-1 18,803,000
+109.39%
 
3,864,056 +144.00%
2025 Q-2 18,880,000 +33.00% 3,500,000 +84.00%
2025 Q-3 14,400,000* -8.00% 1,100,000 -69.00%
2025        
          * Third quarter decrease in revenues were caused by a shipping delay due to Christmas and New Years holidays hitting midweek. When first week of next quarter added to third quarter it becomes the best third quarter ever.

 

Chart
 


 

Board Manager:  NASDAQ2020
Last Updated:  JUNE 16,  2025 by $2.00

 
Top Posts With Reactions
(Last 30 Days)
profile-icon
Dr Speculator Ninja 06/13/25 11:57 AM
🎓️
👍️
📈
25
profile-icon
JamesF1 06/23/25 3:34 PM
🎓️
👍️
💡
24
profile-icon
JamesF1 06/14/25 6:15 AM
👍️
💥
💯
24
profile-icon
Telefon 06/10/25 6:57 PM
👎️
👿
🗑️
24
profile-icon
rocioyogi 05/27/25 1:22 PM
🎓️
👌
👍️
24
profile-icon
JamesF1 06/09/25 12:58 PM
🎓️
👍️
🔥
22
profile-icon
Telefon 06/06/25 4:57 PM
👍️
💯
🗑️
22
profile-icon
NASDAQ2020 06/09/25 5:46 PM
👁️
👍️
👎️
21
profile-icon
$7.00 or Nothing 06/09/25 2:29 PM
🎓️
👍️
💰️
21
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
ELTP Latest News
New Post